
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
latest_posts
- 1
Novartis eyes more bolt-on acquisitions, CEO says - 2
Apollo vs. Artemis: What to know about NASA's return to the moon - 3
A 'rampaging lion' nebula roars to life in a stunning deep-space photo - 4
Ukraine to get up to 100 French-made Rafale fighter jets - 5
Lahav 433 head Asst.-Ch. Meni Benjamin named as police officer investigated for breach of trust
A Texas GOP congressman is retiring. Trump just endorsed his identical twin to replace him.
Eight Muslim nations condemn Israel's 'dangerous' new death penalty law
Finding the Universe of Workmanship: Individual Encounters in Imagination
Fundamental Archives for Beginning Your Business
UN rights chief: Israel's new Gaza aid agency rules 'outrageous'
Building an Individual Brand: Illustrations from Forces to be reckoned with
Cells have more mini ‘organs’ than researchers thought − unbound by membranes, these rogue organelles challenge biology’s fundamentals
Game theory explains why reasonable parents make vaccine choices that fuel outbreaks
7 Fun Plans to Make Film Evenings Seriously Energizing (You'll Cherish #5!)












